MedPath

ibuprofen

Ibuprofen Oral Suspension Drug Facts

Approved
Approval ID

02889717-204c-463b-8506-4c5cf18c77d3

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Mar 3, 2025

Manufacturers
FDA

Padagis Israel Pharmaceuticals Ltd

DUNS: 600093611

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ibuprofen

PRODUCT DETAILS

NDC Product Code45802-897
Application NumberANDA074937
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateMarch 3, 2025
Generic NameIbuprofen

INGREDIENTS (12)

ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
HIGH FRUCTOSE CORN SYRUPInactive
Code: XY6UN3QB6S
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
IBUPROFENActive
Quantity: 100 mg in 5 mL
Code: WK2XYI10QM
Classification: ACTIB
SORBITOL SOLUTIONInactive
Code: 8KW3E207O2
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.